G1 Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2020
Period Ending	Aug '25 Aug 13, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2020
Market Capitalization	18,291	17,521	14,869	4,784	9,818	14,910	Upgrade
Market Cap Growth	4.98%	17.84%	210.82%	-51.28%	-34.15%	3027.44%	Upgrade
Enterprise Value	18,844	17,970	15,077	4,706	8,874	13,977	Upgrade
PS Ratio	3.97	3.81	4.48	2.28	8.62	29.68	Upgrade
PB Ratio	21.28	17.95	19.56	3.87	6.65	6.93	Upgrade
P/TBV Ratio	-	-	-	-	21.15	12.11	Upgrade
P/FCF Ratio	-	44.51	-	-	-	-	Upgrade
P/OCF Ratio	-	43.42	-	-	-	-	Upgrade
EV/Sales Ratio	4.08	3.90	4.55	2.25	7.79	27.82	Upgrade
EV/FCF Ratio	44.09	45.65	-	-	-	-	Upgrade
Debt / Equity Ratio	1.89	1.32	1.60	1.00	0.79	0.03	Upgrade
Debt / FCF Ratio	3.81	3.28	-	-	-	-	Upgrade
Asset Turnover	1.25	1.16	0.92	0.55	0.35	0.33	Upgrade
Quick Ratio	1.00	0.51	0.85	1.09	2.37	3.36	Upgrade
Current Ratio	1.34	0.93	1.34	1.67	2.96	3.96	Upgrade
Return on Equity (ROE)	-26.38%	-54.81%	-74.17%	-91.83%	-70.68%	-95.43%	Upgrade
Return on Assets (ROA)	-4.64%	-8.85%	-12.31%	-23.04%	-25.58%	-26.75%	Upgrade
Return on Capital (ROIC)	-7.24%	-16.07%	-20.33%	-33.09%	-33.63%	-36.83%	Upgrade
Earnings Yield	-1.42%	-2.80%	-4.88%	-26.95%	-13.64%	-6.75%	Upgrade
FCF Yield	2.34%	2.25%	-0.14%	-12.87%	-3.90%	-1.13%	Upgrade
Buyback Yield / Dilution	-4.13%	-4.18%	-5.98%	-8.45%	-31.71%	-65.54%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.